Vincent O’Reilly

947 total citations
15 papers, 780 citations indexed

About

Vincent O’Reilly is a scholar working on Immunology, Rheumatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Vincent O’Reilly has authored 15 papers receiving a total of 780 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 3 papers in Rheumatology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Vincent O’Reilly's work include Immune Cell Function and Interaction (10 papers), T-cell and B-cell Immunology (7 papers) and CAR-T cell therapy research (2 papers). Vincent O’Reilly is often cited by papers focused on Immune Cell Function and Interaction (10 papers), T-cell and B-cell Immunology (7 papers) and CAR-T cell therapy research (2 papers). Vincent O’Reilly collaborates with scholars based in Ireland, United States and Netherlands. Vincent O’Reilly's co-authors include Derek G. Doherty, Andrew E. Hogan, Donal O’Shea, Mark A. Exley, Margaret R. Dunne, Emmanuel Scotet, Pádraic J. Dunne, Ann Atzberger, Fionnuala B. Hickey and Alice M. Coughlan and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Scientific Reports.

In The Last Decade

Vincent O’Reilly

15 papers receiving 770 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vincent O’Reilly Ireland 10 441 154 141 141 110 15 780
Sachin Gupta United States 17 314 0.7× 122 0.8× 156 1.1× 102 0.7× 181 1.6× 47 961
Lauren Young United States 11 511 1.2× 323 2.1× 241 1.7× 134 1.0× 76 0.7× 24 1.1k
Sarah L. Snelgrove Australia 11 350 0.8× 169 1.1× 78 0.6× 109 0.8× 88 0.8× 17 742
Douglas R. Mathern United States 7 324 0.7× 136 0.9× 54 0.4× 88 0.6× 82 0.7× 8 757
Ludmila N. Drutskaya Russia 8 635 1.4× 147 1.0× 117 0.8× 68 0.5× 177 1.6× 9 953
Bhairav Paleja Singapore 10 481 1.1× 246 1.6× 131 0.9× 290 2.1× 293 2.7× 14 949
Honorio Torres‐Aguilar Mexico 15 424 1.0× 157 1.0× 84 0.6× 62 0.4× 44 0.4× 41 717
Michael Judo United States 7 396 0.9× 191 1.2× 72 0.5× 64 0.5× 86 0.8× 7 688
Georges Abboud United States 19 761 1.7× 255 1.7× 124 0.9× 100 0.7× 250 2.3× 45 1.2k
Michael Merger Germany 12 323 0.7× 269 1.7× 178 1.3× 59 0.4× 74 0.7× 21 959

Countries citing papers authored by Vincent O’Reilly

Since Specialization
Citations

This map shows the geographic impact of Vincent O’Reilly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent O’Reilly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent O’Reilly more than expected).

Fields of papers citing papers by Vincent O’Reilly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent O’Reilly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent O’Reilly. The network helps show where Vincent O’Reilly may publish in the future.

Co-authorship network of co-authors of Vincent O’Reilly

This figure shows the co-authorship network connecting the top 25 collaborators of Vincent O’Reilly. A scholar is included among the top collaborators of Vincent O’Reilly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent O’Reilly. Vincent O’Reilly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Dooley, Dearbhaile, Mirjan M. van Timmeren, Vincent O’Reilly, et al.. (2018). Alkylating histone deacetylase inhibitors may have therapeutic value in experimental myeloperoxidase-ANCA vasculitis. Kidney International. 94(5). 926–936. 3 indexed citations
2.
O’Reilly, Vincent, et al.. (2017). Retinoic acid induction of CD1d expression primes chronic lymphocytic leukemia B cells for killing by CD8+ invariant natural killer T cells. Clinical Immunology. 183. 91–98. 17 indexed citations
3.
Coughlan, Alice M., Cathal Harmon, Sarah Whelan, et al.. (2016). Myeloid Engraftment in Humanized Mice: Impact of Granulocyte-Colony Stimulating Factor Treatment and Transgenic Mouse Strain. Stem Cells and Development. 25(7). 530–541. 95 indexed citations
4.
Brennan, Kiva, Brian P. McSharry, Sinéad E. Keating, et al.. (2016). Human Natural Killer cell expression of ULBP2 is associated with a mature functional phenotype. Human Immunology. 77(10). 876–885. 8 indexed citations
5.
Coughlan, Alice M., Cathal Harmon, Sarah Whelan, et al.. (2016). Myeloid engraftment in humanized mice: impact of GCSF treatment and transgenic mouse strain. 1 indexed citations
6.
O’Brien, Eóin C., Wayel H. Abdulahad, Abraham Rutgers, et al.. (2015). Intermediate monocytes in ANCA vasculitis: increased surface expression of ANCA autoantigens and IL-1β secretion in response to anti-MPO antibodies. Scientific Reports. 5(1). 11888–11888. 41 indexed citations
7.
Dunne, Margaret R., Vincent O’Reilly, Pádraic J. Dunne, et al.. (2013). Cutting Edge: CD1d Restriction and Th1/Th2/Th17 Cytokine Secretion by Human Vδ3 T Cells. The Journal of Immunology. 191(1). 30–34. 135 indexed citations
8.
Murphy, Niamh, et al.. (2013). Synthesis and immunostimulatory activity of two α-S-galactosyl phenyl-capped ceramides. ARKIVOC. 2013(2). 363–377. 4 indexed citations
9.
O’Reilly, Vincent, et al.. (2013). Human Invariant NKT Cell Subsets Differentially Promote Differentiation, Antibody Production, and T Cell Stimulation by B Cells In Vitro. The Journal of Immunology. 191(4). 1666–1676. 41 indexed citations
10.
O’Reilly, Vincent, Gabriel Bricard, Ann Atzberger, et al.. (2011). Distinct and Overlapping Effector Functions of Expanded Human CD4+, CD8α+ and CD4-CD8α- Invariant Natural Killer T Cells. PLoS ONE. 6(12). e28648–e28648. 81 indexed citations
11.
Ryan, Anthony W., Mark Lynch, Sinéad M. Smith, et al.. (2011). A Role for TLR4 in Clostridium difficile Infection and the Recognition of Surface Layer Proteins. PLoS Pathogens. 7(6). e1002076–e1002076. 156 indexed citations
12.
Hogan, Andrew E., Vincent O’Reilly, Margaret R. Dunne, et al.. (2011). Activation of human invariant natural killer T cells with a thioglycoside analogue of α-galactosylceramide. Clinical Immunology. 140(2). 196–207. 38 indexed citations
13.
Hogan, Andrew E., Anne‐Marie Tobin, Tomás Ahern, et al.. (2011). Glucagon-like peptide-1 (GLP-1) and the regulation of human invariant natural killer T cells: lessons from obesity, diabetes and psoriasis. Diabetologia. 54(11). 2745–2754. 131 indexed citations
14.
Hogan, Andrew E., Michelle Corrigan, Vincent O’Reilly, et al.. (2011). Cigarette smoke alters the invariant natural killer T cell function and may inhibit anti-tumor responses. Clinical Immunology. 140(3). 229–235. 27 indexed citations
15.
O’Reilly, Vincent. (2004). The Community Trademark System: A Brief Introduction and Overview. 8(1). 93. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026